Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 9Active not recruiting 5Recruiting 2Suspended 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 11Breast 10Gastrointestinal 9Other solid neoplasm 7Thoracic 5Tumor-Agnostic 3Other 3CNS 3Sarcoma 2Other hematologic neoplasm 2Lymphoid 2Gynecologic 2Other neoplasm 1Dermatologic 1

Conditions

Specific Learning Disorder 1Orientation, Spatial 1Lymphoma, Follicular 1Lymphoma 1Learning Disabilities 1Dyscalculia 1Developmental Disabilities 1Cognitive Dysfunction 1Cognition Disorders 1Child Behavior 1Behavior 1

Interventions

Cyclophosphamide 170Rituximab 143Specimen Handling 82venetoclax 79fludarabine 78Vincristine 69obinutuzumab 67Doxorubicin 66Prednisone 65Biopsy 64Magnetic Resonance Spectroscopy 62zanubrutinib 52Lenalidomide 52Dexamethasone 49Methotrexate 43Cytarabine 43blinatumomab 40acalabrutinib 37Immunotherapy, Adoptive 37Bendamustine Hydrochloride 37Etoposide 32fludarabine phosphate 31ibrutinib 28glofitamab 28polatuzumab vedotin 26pirtobrutinib 24orelabrutinib 24Gemcitabine 23Injections 21Mercaptopurine 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Methods × Lymphoid × Clear all
NCT05006482 2026-01-13

GEM-S

University of Rochester

Phase 3 Recruiting
668 enrolled
Lymphoid

Lymphoma

NCT05201534 2025-08-15

Interventions in Mathematics and Cognitive Skills

Stanford University

Phase NA Recruiting
180 enrolled
Lymphoid

Specific Learning Disorder, Orientation, Spatial, Behavior, Child Behavior, Developmental Disabilities, Cognition Disorders, Learning Disabilities, Lymphoma, Follicular, Dyscalculia, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡